XML 33 R133.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment and Geographical Data (Schedule of Segment Reporting Information by Business Segment) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 25, 2015
Jun. 26, 2015
Mar. 27, 2015
Dec. 26, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 25, 2015
Sep. 26, 2014
Sep. 27, 2013
Segment Reporting Information [Line Items]                      
Net sales $ 882.4 $ 877.3 $ 819.0 $ 768.2 $ 673.7 $ 530.1 $ 448.7 $ 429.5 $ 3,346.9 $ 2,082.0 $ 1,712.3
Operating income (loss)                 461.8 (75.9) 73.5
Intangible asset amortization                 (550.3) (154.8) (27.9)
Restructuring and related charges, net                 (40.7) (81.9) (26.3)
Non-restructuring impairment                 0.0 151.6 0.0
Separation costs                 0.0 (9.6) (74.2)
Assets $ 16,404.1       $ 12,787.3       16,404.1 12,787.3  
Depreciation and amortization                 672.5 275.9 139.6
Restructuring and related costs, accelerated depreciation                 0.3 0.5 2.6
Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Restructuring and related charges, net                 (36.5) (57.0) (5.2)
Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Restructuring and related charges, net                 (4.5) (9.8) (11.2)
Operating Segments                      
Segment Reporting Information [Line Items]                      
Net sales [1]                 3,298.2 2,044.6 1,655.2
Operating income (loss)                 1,339.7 550.1 336.2
Operating Segments | Specialty Brands [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 1,622.8 413.5 206.4
Operating income (loss)                 651.3 (50.6) (36.2)
Depreciation and amortization [2]                 559.8 152.9 24.9
Operating Segments | Specialty Generics [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 1,251.6 1,199.4 1,011.2
Operating income (loss)                 622.0 617.4 347.9
Depreciation and amortization [2]                 81.9 77.8 72.7
Operating Segments | Global Medical Imaging                      
Segment Reporting Information [Line Items]                      
Net sales                 423.8 431.7 437.6
Operating income (loss)                 66.4 (16.7) 24.5
Depreciation and amortization [2]                 12.4 18.8 18.5
Corporate, Non-Segment                      
Segment Reporting Information [Line Items]                      
Net sales [3],[4]                 48.7 37.4 57.1
Corporate and allocated expenses [5]                 (286.9) (228.1) (134.3)
Intangible asset amortization                 (550.3) (154.8) (27.9)
Restructuring and related charges, net [6]                 (40.7) (81.9) (26.3)
Non-restructuring impairment                 0.0 (151.6) 0.0
Separation costs                 0.0 (9.6) (74.2)
Intersegment Eliminations                      
Segment Reporting Information [Line Items]                      
Net sales                 0.0 0.0 0.0
Continuing Operations                      
Segment Reporting Information [Line Items]                      
Depreciation and amortization [2]                 $ 654.1 $ 249.5 $ 116.1
[1] Amounts represent sales to external customers. There were no intersegment sales.
[2] Depreciation for certain shared facilities is allocated based on occupancy percentage.
[3] Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
[4] Represents historical CMDS-related intercompany transactions that represent Mallinckrodt continuing operations under an ongoing supply agreement with the acquirer of the CMDS business.
[5] Includes administration expenses and certain compensation, environmental and other costs not charged to the Company's operating segments.
[6] Includes restructuring-related accelerated depreciation.